Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage I-II Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer.
Saved in:
| Title: | Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage I-II Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer. |
|---|---|
| Authors: | Elsayed L; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE., Reed E; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE., Modi S; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE., Tandra PK; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE., Copur MS; Mary Lanning Healthcare, Morrison Cancer Center, Department of Medicine, University of Nebraska Medical Center, Omaha, NE., Samson K; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE., Krishnamurthy J; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE. Electronic address: jairam.krishnamurthy@unmc.edu. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2024 Dec; Vol. 24 (8), pp. 676-682.e1. Date of Electronic Publication: 2024 Jul 17. |
| Publication Type: | Journal Article; Clinical Trial, Phase II |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39261255 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage I-II Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Elsayed+L%22">Elsayed L</searchLink>; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Reed+E%22">Reed E</searchLink>; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Modi+S%22">Modi S</searchLink>; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Tandra+PK%22">Tandra PK</searchLink>; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Copur+MS%22">Copur MS</searchLink>; Mary Lanning Healthcare, Morrison Cancer Center, Department of Medicine, University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Samson+K%22">Samson K</searchLink>; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Krishnamurthy+J%22">Krishnamurthy J</searchLink>; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE. Electronic address: jairam.krishnamurthy@unmc.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100898731%22">Clinical breast cancer</searchLink> [Clin Breast Cancer] 2024 Dec; Vol. 24 (8), pp. 676-682.e1. <i>Date of Electronic Publication: </i>2024 Jul 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100898731 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215268209%22">15268209 </searchLink><i>NLM ISO Abbreviation: </i>Clin Breast Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39261255 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clbc.2024.07.002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 676 Titles: – TitleFull: Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage I-II Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Elsayed L – PersonEntity: Name: NameFull: Reed E – PersonEntity: Name: NameFull: Modi S – PersonEntity: Name: NameFull: Tandra PK – PersonEntity: Name: NameFull: Copur MS – PersonEntity: Name: NameFull: Samson K – PersonEntity: Name: NameFull: Krishnamurthy J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2024 Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1938-0666 Numbering: – Type: volume Value: 24 – Type: issue Value: 8 Titles: – TitleFull: Clinical breast cancer Type: main |
| ResultId | 1 |
